JOINT FILING AGREEMENT
SCHEDULE 13G
CUSIP No. 00000X000
Exhibit 1
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree, as of February 16, 2021, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Xeris Pharmaceuticals, Inc., and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
| By: | /s/ Xxxx Xxxxx | ||
| Xxxx Xxxxx | |||
| Xxxx Xxxxx, individually, as manager of Xxxxx Capital GP, LLC, the general partner of Xxxxx Capital (Master), L.P., and as manager of Xxxxx Capital IM GP, LLC, the general partner of Xxxxx Capital IM, L.P. | |||
| Date: | February 16, 2021 |
